University of Chicago Medicine Comprehensive Cancer Center | Strategic Alliance Partners

Latest from University of Chicago Medicine Comprehensive Cancer Center

GI Armamentarium Undergoes Changes With New Treatment Mechanisms and Applications

January 12, 2022

Chih-Yi (Andy) Liao, MD, discusses the focus of each presentation at the webinar, which centered on optimizing therapy in advanced pancreatic cancer, the contemporary use of surgery and systemic therapy in NETs, multidisciplinary approaches to hepatocellular carcinoma, and the evolving role of liver transplant and systemic therapy.

Dr. Garassino on the Clinical Implications of Tepotinib in METex14-Altered NSCLC

September 24, 2021

Marina Chiara Garassino, MD, professor of Medicine, Hematology and Oncology, The University of Chicago Department of Medicine, discusses the clinical implications of the phase 2 VISION trial evaluating patients with MET exon 14 skipping mutation–positive non–small cell lung cancer.

Garassino Highlights What’s In Store for Lung Cancer

June 21, 2021

Patients with lung cancer were identified as an at-risk group for developing severe complications as a result of SARS-CoV-2 infection, and thoracic oncologists were fast to respond with the establishment of the Thoracic Cancers International COVID-19 Collaboration.